Thursday, 13 August, 2026г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

MSU and Idera: Discussion about Pioneer clinical trial for dermatomyositis

MSU and Idera: Discussion about Pioneer clinical trial for dermatomyositisУ вашего броузера проблема в совместимости с HTML5
As part of Rare Disease Day 2017 and our collaboration with Idera Pharm, we invited Dr. Joanna Horabin to join us for a video chat session to learn more about the currently recruiting, Pioneer clinical trial for adults with dermatomyositis, IMO-8400. To help others learn more about this amazing trial, we recorded it so you can find more information. This trial is active in 17 U.S. locations and 5 outside of the U.S. Idera has made it very easy to be a part of this trial with benefits rarely seen in clinical trials today.
Мой аккаунт